Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Christina
NCT05733611: RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC	Active, not recruiting	2	4	NA	RP2, RP3, atezolizumab, bevacizumab	Replimune Inc., Roche Pharma AG	Refractory Metastatic Colorectal Cancer, pMMR, MSS	01/27	03/27
SRN-707-001, NCT05037149: Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors	Active, not recruiting	1	50	US	STP707, STP707 Powder for Injection	Sirnaomics	Solid Tumor	03/24	03/24
NCT04328740: Phase 1 Study of Oral TP-1454	Active, not recruiting	1	31	US	TP-1454 monotherapy	Sumitomo Pharma America, Inc.	Advanced Solid Tumor, Anal Cancer	03/25	05/25
NCT05189171: MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer	Completed	N/A	46	US	MicroOrganoSphere (MOS) drug screen	Xilis, Inc.	Colorectal Neoplasms	11/23	03/24
Thomas, Sunisha
No trials found